H3K27‐me3 Inhibition Induces YTHDF2‐Mediated Decay of m6A‐Marked Severe Acute Respiratory Syndrome Coronavirus 2 Transcripts
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Ram Kumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Veterinary Type Cultures, ICAR-National Research Centre on Equines, Hisar, India. Hauptthemen laut MEDLINE: SARS-CoV-2, RNA-Binding Proteins, RNA, Viral, RNA Stability. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: This work was supported by the Indian Council of Agricultural Research, New Delhi (grant number IXX14586 to N.K. and NASF/ABA-8027/2020-21 to N.K.)..
Abstract (Originalsprache)
Emerging evidence highlights the role of epigenetic modification in virus infection. In this study, inhibition of H3K27‐methylation (H3K27‐me3) by UNC1999 (H3K27‐methyltransferase inhibitor) was demonstrated to inhibit SARS‐CoV‐2 replication, as evidenced by reduced levels of viral RNA/protein. The m6A modifications of SARS‐CoV‐2 RNA were predominantly present on the 3ʹ end, particularly the “N” gene. The methylated RNA immunoprecipitation (MeRIP) and western‐blot analysis revealed a negative correlation between levels of cellular H3K27‐me3 and m6A‐modifications on the SARS‐CoV‐2 “N” gene. Moreover, m6A‐modifications of the SARS‐CoV‐2 “N” gene were shown to promote the recruitment of YTHDF2, which eventually resulted in decay of the viral transcripts. The application of the H3K27‐demethyltransferase or KDM6A/B inhibitor GSK‐J4 can restore H3K27‐me3 levels and mitigating the decay of viral mRNA in UNC1999‐treated SARS‐CoV‐2‐infected cells. Furthermore, long‐term sequential passage (P = 50) of the virus in the presence of UNC1999 did not yield any UNC1999‐resistant SARS‐CoV‐2 mutants. In conclusion, by integrating transcriptomics, molecular virology and functional analyses, we for the first time demonstrated that inhibition of H3K27‐me3 induces m6A‐mediated decay of SARS‐CoV‐2 transcripts, highlighting UNC1999 as novel antiviral candidate against SARS‐CoV‐2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Centre for Veterinary Type Cultures, ICAR-National Research Centre on Equines, Hisar, India.
- TARE fellow, Science and Engineering Research Board (SERB), New Delhi, India.
ORCID-Profile: Naveen Kumar
Förderung
- This work was supported by the Indian Council of Agricultural Research, New Delhi (grant number IXX14586 to N.K. and NASF/ABA-8027/2020-21 to N.K.).
Zitieren
APA
Kumar, R., Verma, A., Kamboj, H., Bhattacharya, T. K., Barua, S., Tripathi, B. N., Sharma, S., & Kumar, N. (2025). H3K27‐me3 Inhibition Induces YTHDF2‐Mediated Decay of m6A‐Marked Severe Acute Respiratory Syndrome Coronavirus 2 Transcripts. Journal of Medical Virology. https://doi.org/10.1002/jmv.70332
Vancouver
Kumar R, Verma A, Kamboj H, Bhattacharya TK, Barua S, Tripathi BN, et al. H3K27‐me3 Inhibition Induces YTHDF2‐Mediated Decay of m6A‐Marked Severe Acute Respiratory Syndrome Coronavirus 2 Transcripts. Journal of Medical Virology. 2025. doi:10.1002/jmv.70332
BibTeX
@article{Kumar2025,
author = {Kumar, Ram and Verma, Assim and Kamboj, Himanshu and Bhattacharya, Tarun K and Barua, Sanjay and Tripathi, Bhupendra N and Sharma, Shalini and Kumar, Naveen},
title = {H3K27‐me3 Inhibition Induces YTHDF2‐Mediated Decay of m6A‐Marked Severe Acute Respiratory Syndrome Coronavirus 2 Transcripts},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70332}
}
EUVIMED